Francois Dalencon

Title: The Innovative Contributions of Francois Dalencon

Introduction

Francois Dalencon is a notable inventor based in Lyons, France. He has made significant contributions to the field of immunology, particularly through his innovative patents. With a total of 2 patents, Dalencon's work focuses on developing immunogenic compositions and adjuvant emulsions.

Latest Patents

Dalencon's latest patents include groundbreaking inventions in the realm of immunogenic compositions. One of his notable inventions provides compositions comprising a Chlamydial major outer membrane protein (MOMP) from at least one Chlamydial serovar and an adjuvant. This adjuvant includes the product E6020, characterized by its CAS Number 287180-63-6. The composition may also incorporate various carrier systems, such as emulsions or mineral particles. Additionally, Dalencon has developed an oil-in-water adjuvant emulsion, which is created through a temperature-variation phase-inversion process. This emulsion is designed to mix with at least one vaccine antigen, enhancing the efficacy of immunogenic compositions.

Career Highlights

Throughout his career, Dalencon has worked with prominent companies in the pharmaceutical industry, including Sanofi Pasteur SA and Sanofi Pasteur Inc. His experience in these organizations has allowed him to contribute to significant advancements in vaccine development and immunology.

Collaborations

Dalencon has collaborated with esteemed colleagues, including Marie-Francoise Klucker and Patricia Probeck-Quellec. These partnerships have fostered a collaborative environment that promotes innovation and the sharing of ideas in the field of immunology.

Conclusion

Francois Dalencon's contributions to immunology through his patents and collaborations highlight his role as an influential inventor. His work continues to impact the development of effective immunogenic compositions and adjuvants, paving the way for advancements in vaccine technology.